[
  {
    "ts": "2025-07-15T14:09:16+00:00",
    "headline": "Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH)",
    "summary": "Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the rest of the market, experienced a strong rebound after the tariff-induced sell-off at the start of the quarter. The portfolio gained […]",
    "url": "https://finance.yahoo.com/news/headwaters-capital-management-investment-thesis-140916079.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4624a9b8-171f-3ceb-b83c-bc24aae453a5",
      "content": {
        "id": "4624a9b8-171f-3ceb-b83c-bc24aae453a5",
        "contentType": "STORY",
        "title": "Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH)",
        "description": "",
        "summary": "Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the rest of the market, experienced a strong rebound after the tariff-induced sell-off at the start of the quarter. The portfolio gained […]",
        "pubDate": "2025-07-15T14:09:16Z",
        "displayTime": "2025-07-15T14:09:16Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4ac7824d91c023fe3b0d130d35a6f0a2",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fn0Lr6B7RKdFyh8xI_o.tA--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4ac7824d91c023fe3b0d130d35a6f0a2.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bYW2wXed_o9aS87i.YkYlg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4ac7824d91c023fe3b0d130d35a6f0a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/headwaters-capital-management-investment-thesis-140916079.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/headwaters-capital-management-investment-thesis-140916079.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T13:03:00+00:00",
    "headline": "Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology",
    "summary": "WOBURN, Mass., July 15, 2025--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking SPEAR UltraDetect™ immunoassays, focusing initially on the",
    "url": "https://finance.yahoo.com/news/spear-bio-announces-strategic-partnership-130300447.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "4c738d95-8625-3f6f-aa71-1d44b0b82bb9",
      "content": {
        "id": "4c738d95-8625-3f6f-aa71-1d44b0b82bb9",
        "contentType": "STORY",
        "title": "Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology",
        "description": "",
        "summary": "WOBURN, Mass., July 15, 2025--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking SPEAR UltraDetect™ immunoassays, focusing initially on the",
        "pubDate": "2025-07-15T13:03:00Z",
        "displayTime": "2025-07-15T13:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/245b224eb52ca4f55cedaac52faea44c",
          "originalWidth": 1271,
          "originalHeight": 245,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UL9vggdQ8tw8gn.lohW8dw--~B/aD0yNDU7dz0xMjcxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/245b224eb52ca4f55cedaac52faea44c.cf.webp",
              "width": 1271,
              "height": 245,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dhmAjJZdPK_d51WLuXLhDw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/245b224eb52ca4f55cedaac52faea44c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/spear-bio-announces-strategic-partnership-130300447.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/spear-bio-announces-strategic-partnership-130300447.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T11:00:00+00:00",
    "headline": "Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio's ultrasensitive immunoassays for challenging low-abundance biomarkers, including key Alzheimer's disease biomarkers such as phosphorylated tau 217 (pTau 217), GFAP, neurofilament light (Nf-L), and phosphorylated tau 231 (pTau 2",
    "url": "https://finance.yahoo.com/news/bio-techne-spear-bio-announce-110000024.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "3e8c92d9-da7c-3876-8ff1-f75ba22eabcf",
      "content": {
        "id": "3e8c92d9-da7c-3876-8ff1-f75ba22eabcf",
        "contentType": "STORY",
        "title": "Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection",
        "description": "",
        "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio's ultrasensitive immunoassays for challenging low-abundance biomarkers, including key Alzheimer's disease biomarkers such as phosphorylated tau 217 (pTau 217), GFAP, neurofilament light (Nf-L), and phosphorylated tau 231 (pTau 2",
        "pubDate": "2025-07-15T11:00:00Z",
        "displayTime": "2025-07-15T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c",
          "originalWidth": 400,
          "originalHeight": 146,
          "caption": "BT Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kJl8lfxgQq52fwY.Vvxfgw--~B/aD0xNDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c.cf.webp",
              "width": 400,
              "height": 146,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tkFsOYbYoGS0nXbE3BaqwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-spear-bio-announce-110000024.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-spear-bio-announce-110000024.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]